Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Dafadine-A | 1065506-69-5 | 98.9% | 391.46 | 1 ML
SDP

Catalog No. 5000394626
Encompass_Preferred

Dafadine-A is a selective inhibitor of DAF-9 cytochrome P450 in the nematode *Caenorhabditis elegans*. It inhibits the mammalian ortholog of DAF-9 (CYP27A1) but does not inhibit DAF-12, or sterol- and oxysterol-metabolizing P450s. It is for research use only.

  • Induces a constitutive dauer formation (Daf-c) phenotype in more than 30% of wild-type *Caenorhabditis elegans* at 12.5 μM.
  • Causes a protruding vulva (Pvl) phenotype and distal-tip cell migration (Mig) defects in over 60% of wild-type *Caenorhabditis elegans* at 25 μM.
  • Inhibits the ability of CYP27A1 to metabolize 4-cholesten-3-one at 5 μM.
  • Extends the lifespan of wild-type *Caenorhabditis elegans* by 29%.
  • Dramatically inhibits cholesterol-induced melanoma spheroid propagation and downregulates Rap1A/Rap1B expression and phosphorylated AKT1-thr308/309 at 5-10 μM (48 h).
  • Significantly enhances Vemurafenib-induced apoptosis at 10 μM (48 h).

Catalog No. 50-003-94626 Supplier Medchemexpress LLC Supplier No. HY1667010MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Dafadine-A is a selective inhibitor of DAF-9 cytochrome P450 in the nematode *Caenorhabditis elegans*. It inhibits the mammalian ortholog of DAF-9 (CYP27A1) but does not inhibit DAF-12, or sterol- and oxysterol-metabolizing P450s. It is for research use only.

  • Induces a constitutive dauer formation (Daf-c) phenotype in more than 30% of wild-type *Caenorhabditis elegans* at 12.5 μM.
  • Causes a protruding vulva (Pvl) phenotype and distal-tip cell migration (Mig) defects in over 60% of wild-type *Caenorhabditis elegans* at 25 μM.
  • Inhibits the ability of CYP27A1 to metabolize 4-cholesten-3-one at 5 μM.
  • Extends the lifespan of wild-type *Caenorhabditis elegans* by 29%.
  • Dramatically inhibits cholesterol-induced melanoma spheroid propagation and downregulates Rap1A/Rap1B expression and phosphorylated AKT1-thr308/309 at 5-10 μM (48 h).
  • Significantly enhances Vemurafenib-induced apoptosis at 10 μM (48 h).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.